IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $811,550 | +231110.8% | 115,277 | +100.4% | 0.01% | +100.0% |
| Q1 2023 | $351 | -42.0% | 57,527 | -39.2% | 0.01% | -58.3% |
| Q4 2022 | $605 | -99.9% | 94,629 | +20.1% | 0.01% | -25.0% |
| Q3 2022 | $755,000 | -24.4% | 78,780 | -12.9% | 0.02% | -38.5% |
| Q2 2022 | $999,000 | +97.4% | 90,494 | +198.0% | 0.03% | +116.7% |
| Q1 2022 | $506,000 | -69.7% | 30,370 | -65.3% | 0.01% | -57.1% |
| Q4 2021 | $1,671,000 | +41.3% | 87,532 | +82.4% | 0.03% | +47.4% |
| Q3 2021 | $1,183,000 | -75.1% | 47,982 | -68.0% | 0.02% | -80.0% |
| Q1 2021 | $4,752,000 | +441.8% | 150,091 | +369.9% | 0.10% | +120.9% |
| Q2 2020 | $877,000 | +496.6% | 31,938 | +68.1% | 0.04% | +975.0% |
| Q3 2017 | $147,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |